Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Akero Therapeutics, Inc. - Common Stock
(NQ:
AKRO
)
54.74
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 8, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Akero Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Novo Nordisk Loses Metsera Bidding War To Pfizer — But Retail Traders Aren’t Losing Faith
↗
November 09, 2025
Novo investors on Stocktwits praised new CEO Mike Doustdar as “dynamic,” saying they remain confident in Novo’s long-term obesity and diabetes pipeline despite short-term setbacks.
Via
Stocktwits
Omeros Catapults Almost 150% On A Surprise $2.1 Billion Deal With Novo Nordisk
↗
October 15, 2025
Novo Nordisk is licensing exclusive global rights to the company's experimental treatment for rare blood and kidney diseases.
Via
Investor's Business Daily
This Keysight Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
↗
October 10, 2025
Via
Benzinga
Wall Street Pulls Back as Earnings Season Kicks Off; PepsiCo, Delta, and Costco Defy the Trend
↗
October 10, 2025
U.S. markets took a step back on Thursday, with the Dow and Nasdaq closing lower. Still, some heavyweights bucked the trend: PepsiCo, Delta Air Lines, and Costco all reported stronger-than-expected...
Via
Chartmill
Topics
Stocks
This Stock Just Doubled in 1 Day -- Is It Still a Buy?
↗
February 02, 2025
Via
The Motley Fool
Why Akero Therapeutics Stock Trounced the Market on Thursday
↗
October 09, 2025
The biotech will soon have a new owner.
Via
The Motley Fool
Delta Air Lines, Tilray Brands, UiPath, Akero Therapeutics, Apogee Therapeutics: Stocks Making The Biggest Moves Today
↗
October 09, 2025
Via
Stocktwits
Tilray Brands Posts Upbeat Results, Joins Byrna Technologies, Delta Air Lines And Other Big Stocks Moving Higher On Thursday
↗
October 09, 2025
Via
Benzinga
Novo Nordisk To Acquire Liver Disease Focused Akero Therapeutics For Around $5 Billion
↗
October 09, 2025
Novo Nordisk to buy Akero Therapeutics for up to $5.2 billion, adding EFX, a late-stage MASH treatment candidate, to its metabolic disease portfolio.
Via
Benzinga
Novo Nordisk Bulks Up Its Obesity-Tied Portfolio With $4.7 Billion Buyout
↗
October 09, 2025
The deal follows Roche's plan to buy 89bio, another MASH-focused biotech company.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
October 09, 2025
Via
Benzinga
Dow Futures Inch Up As Wall Street Awaits Jerome Powell’s Speech: TSLA, NVO, DAL, PEP Among Stocks To Watch
↗
October 09, 2025
Via
Stocktwits
Topics
Economy
Stocks
What’s Driving The Super Rally In Akero Shares On Thursday Morning?
↗
October 09, 2025
Novo Nordisk is set to acquire the firm, and Akero’s shareholders will receive $54 per share in cash at closing in addition to a contingent value right.
Via
Stocktwits
Akero Therapeutics Inc (NASDAQ:AKRO) Reports Q2 2025 Earnings: Narrower Loss and Clinical Progress Drive Investor Optimism
↗
August 08, 2025
Akero Therapeutics reports Q2 2025 results with narrower-than-expected loss, strong cash reserves, and promising clinical progress in MASH treatment. Stock gains 6.5% pre-market.
Via
Chartmill
Akero (AKRO) Q2 Loss Narrows 6%
↗
August 08, 2025
Via
The Motley Fool
This AeroVironment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
↗
August 04, 2025
Via
Benzinga
AKERO THERAPEUTICS INC (NASDAQ:AKRO) - A Strong Technical Setup in Biotech
↗
July 18, 2025
AKERO THERAPEUTICS (NASDAQ:AKRO) shows strong technicals with a perfect 10 rating and a high-quality breakout setup, making it a stock to watch for traders.
Via
Chartmill
Jefferies Names Akero Therapeutics, Scholar Rock As Biotech Companies With Takeover Potential, But Retail Isn’t Pleased
↗
June 13, 2025
Jefferies thinks big pharma companies are "still on the hunt" for deals.
Via
Stocktwits
Akero Therapeutics Stock Rallies To 3-Month High On Buyout Report; Retail Investors Turn Bullish
↗
May 20, 2025
The company reportedly hired an investment bank to explore a possible sale.
Via
Stocktwits
10 Health Care Stocks With Whale Alerts In Today's Session
↗
May 20, 2025
Via
Benzinga
Best Biotech Stocks to Buy in 2025
May 13, 2025
Discover the best biotech stocks of 2025, including top performers like Vertex and Regeneron, driven by clinical breakthroughs and strong investor momentum.
Via
MarketBeat
Topics
ETFs
Economy
Government
10 Health Care Stocks With Whale Alerts In Today's Session
↗
April 01, 2025
Via
Benzinga
The Stock Market Hates Uncertainty & Loves To Climb A Wall-Of-Worry
↗
March 21, 2025
In this video lesson, I review the overall market and a new swing position for Monday's session.
Via
Talk Markets
Topics
ETFs
Stocks / Equities
10 Health Care Stocks Whale Activity In Today's Session
↗
March 21, 2025
Via
Benzinga
3 Mid-Caps Worth Watching Closely in March
February 28, 2025
Unlike their mega-cap counterparts, which tend to grind, mid-caps can soar or crash within days, driven by headlines and pure speculation.
Via
MarketBeat
Akero Therapeutics, Brinker International And Viavi Are Among Top Mid Cap Gainers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio?
↗
February 02, 2025
Check out this week's top-performing mid-cap stocks, including Akero Therapeutics' remarkable 106.57% surge following positive clinical trial results and other companies like Surgery Partners...
Via
Benzinga
9 Health Care Stocks With Whale Alerts In Today's Session
↗
January 28, 2025
Via
Benzinga
Royal Caribbean Cruises Posts Upbeat Earnings, Joins Brighthouse Financial, Invesco, Boeing And Other Big Stocks Moving Higher On Tuesday
↗
January 28, 2025
Via
Benzinga
McDonald's To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday
↗
January 28, 2025
Via
Benzinga
Which stocks are experiencing notable movement on Monday?
↗
January 27, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
